People in the News
Roxi Wen has been appointed as CFO of Invitae, effective June 21. She will replace Shelly Guyer, who will focus on the company's environment, social, and governance efforts. Wen joins Invitae from Mozilla, where she has been CFO. Prior to that, she was CFO at Elo Touch Solutions, and before that, VP of finance at FleetPride. Previously, she was CFO at General Electric Critical Power. Wen holds a bachelor of economics from Xiamen University and an MBA from the University of Minnesota.
Katherine Stueland will step down as chief commercial officer of Invitae, effective June 18, to become CEO at another company.
GenapSys has appointed Loretta Cecil, Fredrik Eliasson, and Diana McKenzie to its board of directors.
Cecil is executive VP and general counsel at healthcare software firm Change Healthcare. Previously, she was senior VP of governance relations at McKesson and general counsel for McKesson Technology Solutions. She holds a JD from the University of North Carolina at Chapel Hill and a BA in political science and communication studies from the University of North Carolina at Greensboro.
Eliasson is executive VP and CFO at Change Healthcare. Previously, he held various roles, including executive VP, chief sales and marketing officer, and CFO, at CSX Corporation. He holds MBA and BA degrees from Virginia Commonwealth University.
McKenzie is the former chief information officer of Workday. Before that, she had the same role at Amgen, and prior to that, she held IT and other positions at Eli Lilly. She has a BS in computer information systems and computer technology from Purdue University.
Genialis has added four people to its team, including two senior executives. Mojca Valjavec has joined as head of compliance and regulatory operations, and has already helped the firm earn ISO 27000 recertification. Robyn Schlicher, who has a background in precision diagnostics, has been named director of business development strategy. Genialis has also hired Daniel Pointing and Sukhi Singh as domain experts, in the areas of partnership development and in findable, accessible, interoperable, and reproducible (FAIR) data standards, respectively.
SphingoTec has appointed Angelo Moesslang as its CFO and managing director. Prior to joining SphingoTec, he served as CEO of a US-based medical device startup and held executive roles with the Fresenius Group in Europe, Asia, and the US. Most recently, he was CFO of Fresenius Medical Care North America.
Personal Genome Diagnostics has appointed Brent Dial as its CFO. He previously served as principal at Chordata Ventures. Prior to that, he was CFO of Anheuser-Busch's High End division. He also held positions at JP Morgan Chase, Deutsche Bank Securities, and TCOM. Dial holds an MBA in corporate finance from the University of Pennsylvania’s Wharton School and is a graduate of the United States Military Academy.
Justin O'Grady has joined Oxford Nanopore Technologies as senior director of translational applications. Previously, he was a senior lecturer in medical microbiology at the University of East Anglia, and before that, a group leader at the Quadram Institute. He holds PhD, MSc, and BSc degrees in microbiology from the National University of Ireland, Galway.
Mini mass spectrometry device maker 908 Devices has appointed Marcia Eisenberg, CSO of Labcorp Diagnostics, to its board of directors. She previously held roles on the National Institute of Environmental Health Sciences and the FBI’s National DNA Advisory Board and has extensive experience with forensic DNA testing, biotechnology, molecular genetics, and molecular oncology, according to Boston-based 908 Devices.
Pacific Biosciences has appointed Neil Ward as VP and general manager for Europe, the Middle East, and Africa.
Ward comes to PacBio from Illumina, where he was senior sales director for Northern Europe. Prior to his 13 years at Illumina, he held bioinformatics and sales roles at Agilent Technologies, Silicon Genetics, Oxford Biomedica, and Celltech. Ward holds a master's degree in bioinformatics from the University of Manchester.
Bionano Genomics has appointed Jason Priar as chief commercial officer. He will lead the commercial teams in the firm's platforms and services businesses.
Priar comes to Bionano from PerkinElmer Genomics, where he was VP of commercial in the firm's global labs business. Previously, he led sales at Sema4 and GeneDx.
KCAS Bioanalytical and Biomarker Services has named John Pirro as senior director of biopharmaceutical services. He joins the company from WuXi AppTec, where he was head of large- and small-molecule customer bioassays and clinical diagnostic development programs. He holds a BS in cell biology from the University of Iowa.